Vasopressors

Background

The goal of vasopressor use is to reach critical organ perfusion pressure. Estimated required mean arterial pressures (MAP) are listed below. It is generally safe to aim for a goal map of 65 mmHg. Vasopressors also promote increased venous return.

  • Brain: MAP of 50 mmHg [1]
  • Heart: MAP of 65 mmHg[2]
  • Kidneys: MAP 65-75 mmHg[3]

IV Vasopressor have not been shown to be unsafe when used peripherally[4] If running peripherally perform frequent site check via institutional protocol. [5]

Norepinephrine

Dopamine

Dobutamine

Phenylephrine

Vasopressin

Epinephrine

Indication

  • Anaphylaxis

Primary Receptor

  • β1
  • α1
  • β2

Relative Effects

  • ↑↑↑HR
  • ↑↑↑SV
  • ↑↑↑SVR
  • Bronchodilation (β2)

Dosing

  • Dose-dependent effects:
  • 1-10 mcg/min - increase HR and SV
  • 10-20 mcg/min - increase SVR

Rate of Titration

  • Q2-5 min

Adverse Effects

  • Tachyarrhythmias
  • Myocardial ischemia
  • ↑Serum lactate
  • Splanchnic ischemia

Notes

  • ↑lactate occurs primarily from ↑glycolysis/glycogenolysis within skeletal muscles not tissue hypoperfusion
  • Use with caution in pts with CAD
    • However clinical trials have not demonstrated worsened outcomes

Milrinone

Indication

low cardiac output states due to impaired myocardial contractility

Primary Receptor

  • PDE-3 inhibitor

Relative Effects

  • ↑HR
  • ↑↑↑SV
  • ↓SVR

Dosing

  • Normal renal function:

0.25 - 0.75 mcg/kg/min

  • Creatinine clearance < 50mL/min, reduce infusion rate

Rate of Titration

  • Q2H; slower titration rate if renal insufficiency

Adverse Effects

  • Tachyarrhythmias
  • Hypotension
  • Myocardial ischemia

Notes

  • Can use as alternative to dobutamine in pts with cardiogenic shock and on b-blockers
  • Causes pulmonary vasodilation, may be good choice in pts with RV failure
  • ↑cAMP in cardiac myocytes and vascular smooth muscle, thereby ↑HR and ↑SV while decreasing ↓SVR
  • Use with caution in pt with renal failure and hypovolemia

Push Dose Pressors

  • Use when need temporary BP or CO boost
    • Post-intubation hypotension
    • Propofol-induced hypotension
    • A-fib w/ hypotension
      • Easier to convert well-perfused heart

Epinephrine

  • Mix 9mL of NS with 1mL of 1:10,000 epi
    • Now have 10mL of 10mcg/mL
      • Use 0.5-2mL q2-5min (similar to epi drip)
      • Same as 2% lido with epi
        • Ok to give peripherally
  • Onset - 1min
  • Duration - 5-10min

Phenylephrine

  • Pure alpha (no effect on heart)
  • Place 1mL of 10mg/mL vial in 100mL NS
    • Now have 100mcg/mL
    • Draw up 10mL
    • Use 0.5-2mL q2-5min (50-200mcg)
  • Onset - 1min
  • Duration - 20min

Source

  1. Plöchl, W, D J Cook, T A Orszulak, and R C Daly. 1998. Critical cerebral perfusion pressure during tepid heart operations in dogs. The Annals of thoracic surgery, no. 1. http://www.ncbi.nlm.nih.gov/pubmed/9692450
  2. Emcrit Vasopressor basics http://emcrit.org/podcasts/vasopressor-basics/
  3. Bellomo, Rinaldo, Li Wan, and Clive May. 2008. Vasoactive drugs and acute kidney injury. Critical care medicine, no. 4 Suppl. doi:10.1097/CCM.0b013e318169167f. http://www.ncbi.nlm.nih.gov/pubmed/18382191.
  4. Ricard JD. et al. Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial. Crit Care Med. 2013 Sep;41(9):2108-15
  5. Chen J. et al. Extravasation injury associated with low-dose dopamine.. Ann Pharmacother. 1998 May;32(5):545-8
  • EmCrit Podcast 6